A comprehensive overview of oncogenic pathways in human cancer
暂无分享,去创建一个
Jing Xiao | Yingqi Xu | Jian Huang | Chunlong Zhang | Feng Li | Xia Li | Yunpeng Zhang | Tan Wu | Jianxia Gao | Qun Dong | Yanjun Xu | Qian Li | Liqiu Liu | Xiaoxu Hu | Yunpeng Zhang | Yanjun Xu | Feng Li | Tan Wu | Chunlong Zhang | Xia Li | Yingqi Xu | Jian Huang | Qun Dong | Xiaoxu Hu | Liqi Liu | Jianxiang Gao | Jing Xiao | Qian Li
[1] Russ B. Altman,et al. Missing value estimation methods for DNA microarrays , 2001, Bioinform..
[2] Kaleigh Fernald,et al. Evading apoptosis in cancer. , 2013, Trends in cell biology.
[3] Howard Y. Chang,et al. Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.
[4] Kun-Liang Guan,et al. Mechanisms of Hippo pathway regulation , 2016, Genes & development.
[5] Michal Sheffer,et al. Pathway-based personalized analysis of cancer , 2013, Proceedings of the National Academy of Sciences.
[6] Rebecca L. Siegel Mph,et al. Cancer statistics, 2018 , 2018 .
[7] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[8] Weiying Zhou,et al. Breast cancer-secreted miR-122 reprograms glucose metabolism in pre-metastatic niche to promote metastasis , 2015, Nature Cell Biology.
[9] Gregory P. Way,et al. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas , 2018, Cell reports.
[10] Mark A Feitelson,et al. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. , 2015, Seminars in cancer biology.
[11] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[12] Yun Ye,et al. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer , 2018, PloS one.
[13] William C Reinhold,et al. CellMiner: a relational database and query tool for the NCI-60 cancer cell lines , 2009, BMC Genomics.
[14] Hiroko K. Solvang,et al. Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer , 2011, BMC Bioinformatics.
[15] Yuan Yuan,et al. MicroRNA‐590‐5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial–mesenchymal transition by downregulating the Wnt–β‐catenin signaling pathway , 2018, Journal of cellular physiology.
[16] Brämer Gr. International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[17] Ugur Dogrusoz,et al. PathwayMapper: a collaborative visual web editor for cancer pathways and genomic data , 2017, Bioinform..
[18] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[19] Andrew E. Teschendorff,et al. Tissue-independent and tissue-specific patterns of DNA methylation alteration in cancer , 2016, Epigenetics & Chromatin.
[20] Ervin H. Epstein,et al. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma , 2016, Molecular Cancer Therapeutics.
[21] Yibo Wu,et al. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products , 2010, Bioinform..
[22] O. Franco,et al. Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study , 2017, Systematic Reviews.
[23] Steven J. M. Jones,et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.
[24] Min Shi,et al. Long noncoding RNA DGCR5 represses hepatocellular carcinoma progression by inactivating Wnt signaling pathway , 2018, Journal of cellular biochemistry.
[25] Taesung Park,et al. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer , 2017, Cancer.
[26] William C Reinhold,et al. Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel , 2006, Molecular Cancer Therapeutics.
[27] Hu Chen,et al. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. , 2018, Cell reports.
[28] Margit Rosner,et al. Human stem cells alter the invasive properties of somatic cells via paracrine activation of mTORC1 , 2017, Nature Communications.
[29] Leng Han,et al. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer , 2018, Cell reports.
[30] Ilya Mazo,et al. Clustering Gene Expression Regulators: New Approach to Disease Subtyping , 2014, PloS one.
[31] Lovelace J. Luquette,et al. A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations. , 2017, Cancer cell.
[32] Fang Wang,et al. Inhibitory role of large intergenic noncoding RNA‐ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway , 2018, Journal of cellular physiology.
[33] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[34] P. Iengar. Identifying pathways affected by cancer mutations. , 2017, Genomics.
[35] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[36] David García-Dorado,et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. , 2009, Cancer cell.
[37] Ming Lei,et al. Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells , 2017, Theranostics.
[38] Min Pan,et al. A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers , 2012, Genome research.